Literature DB >> 15889524

Effects of shenmai injection on blood SOD activity and MDA level in senile patients with coronary heart disease.

Xianming Su1, Yi Ma, Ruowen Huang, Xiaohong Wang, Yongxing Wang.   

Abstract

In order to approach the effects of Shenmai Injection on SOD activity and MDA level in the senile patients with coronary heart disease, 48 cases, who had stenosis of over 70% in more than one branches of the coronary arteries, were assigned randomly into a treatment group (given Shenmai Injection plus the routine treatment) and a control group (given the routine treatment only). The superoxide dismutase (SOD) activity and malondialdehyde (MDA) level were determined before treatment and at the end of a 3-week treatment. The results showed that in the treatment group, the SOD activity was significantly increased (P<0.05) and the MDA level markedly decreased (P<0.01) in the treatment group. It can be concluded that Shenmai Injection may enhancethe antioxidant ability of the senile patients with coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889524

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  7 in total

1.  Effect of Dan Hong injection on PON1, SOD activity and MDA levels in elderly patients with coronary heart disease.

Authors:  Xianming Su; Yajun He; Wei Yang; Ying Wang; Wei Zhang; Ying Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Pretreatment with Shenmai Injection Protects against Coronary Microvascular Dysfunction.

Authors:  Zhaohai Zheng; Zhangjie Yu; Buyun Xu; Yan Zhou; Yangbo Xing; Qingsong Li; Weiliang Tang; Fang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-09       Impact factor: 2.650

3.  Effect of two administration routes of Shenmai Injection () on pulmonary gas exchange function after tourniquet-induced ischemia-reperfusion.

Authors:  Jian-Guo Jin; Hai-Jian Shen; Yuan-Lu Shan; Lei Chen; Xi-Yue Zhao; Liang-Rong Wang; Li-Na Lin
Journal:  Chin J Integr Med       Date:  2016-06-14       Impact factor: 1.978

4.  Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model.

Authors:  Xingcai Zhang; Yuli Cai
Journal:  Exp Ther Med       Date:  2018-09-05       Impact factor: 2.447

5.  YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α.

Authors:  Yichao Zhao; Longwei Xu; Zhiqing Qiao; Lingchen Gao; Song Ding; Xiaoying Ying; Yuanyuan Su; Nan Lin; Ben He; Jun Pu
Journal:  Sci Rep       Date:  2016-03-11       Impact factor: 4.379

6.  Metabonomic strategy to the evaluation of chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats.

Authors:  Xue Xin; Haimiao Zou; Ningning Zheng; Xinchun Xu; Yinmin Liu; Xiaoxian Wang; Hongbing Wu; Lina Lu; Jing Su; Mingfeng Qiu; Xiaoyan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629

7.  Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.

Authors:  Wei-Jian Zhang; Wei-Wei Su; Qing-Wei Lin; Yan He; Zeng-Hao Yan; Yong-Gang Wang; Pei-Bo Li; Hao Wu; Hong Liu; Hong-Liang Yao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.